Kumamoto University Hospital, Cardiovascular Medicine

Kumamoto-shi, Kumamoto 860-8556

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis — Completed
• A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis — Running, not enrolling